| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Sarcoma | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Gastrointestinal Stromal Tumors | |||||
| 3 | More general conditions related to this trial | ||||
| Digestive System Diseases | |||||
| Digestive System Neoplasms | |||||
| Gastrointestinal Diseases | |||||
| Gastrointestinal Neoplasms | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Connective and Soft Tissue | |||||
| 4 | Interventions listed in this trial | ||||
| PTK787/ZK222584 | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Endothelial Growth Factors | |||||
| Vatalanib | |||||
| 6 | More general drug interventions related to this trial | ||||
| Enzyme Inhibitors | |||||
| Growth Substances | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protein Kinase Inhibitors | |||||
| 7 | Sponsors listed in this trial | ||||
| Helsinki University | |||||
| Bayer | |||||
|
